col-md-1

EARLYBIRD OFFER EXPIRES INCountdown

col-md-1

2017 SPEAKERS INCLUDE:

  • Dr Joanne Kurtzberg at World Precision Medicine Congress
    Dr Joanne Kurtzberg
    Director
    Carolinas Cord Blood Bank At Duke
    Mr Alastair Kent OBE at World Precision Medicine Congress
    Mr Alastair Kent OBE
    Director
    Genetic Alliance U.K.
  • Dr Catalina Lopez-Correa at World Precision Medicine Congress
    Dr Catalina Lopez-Correa
    Vice-President, Sector Development & Chief Scientific Officer
    Genome British Columbia
    Dr Moshe Israeli at World Precision Medicine Congress
    Dr Moshe Israeli
    Director of Tissue Typing Laboratory
    Rabin Medical Center
  • Gil Van Bokkelen at World Precision Medicine Congress
    Gil Van Bokkelen
    Chairman and Chief Executive Officer
    Athersys, Inc.
    Dr David Wedge at World Precision Medicine Congress
    Dr David Wedge
    Group Leader in Cancer Genomics
    University of Oxford, Big Data Institute
  • Dr David Pearce at World Precision Medicine Congress
    Dr David Pearce
    President
    Sanford Research
    Silviu Itescu at World Precision Medicine Congress
    Silviu Itescu
    Chief Executive Officer and Managing Director
    Mesoblast
  • Ms Charis Ober at World Precision Medicine Congress
    Ms Charis Ober
    Founder and Executive Director
    Save the Cord Foundation
    Dr Jaap Boelens at World Precision Medicine Congress
    Dr Jaap Boelens
    Haemato Oncologist
    UMC Utrecht
  • Jeffrey D Abbey at World Precision Medicine Congress
    Jeffrey D Abbey
    President and Chief Executive Officer
    Argos Therapeutics
    Dr Detlef Bockenhauer at World Precision Medicine Congress
    Dr Detlef Bockenhauer
    Clinical Professor of Paediatric Nephrology
    UCL
  • Katy Spink at World Precision Medicine Congress
    Katy Spink
    Chief Operating Officer
    Asterias Biotherapeutics Inc
    Professor Margaret Sleeboom-Faulkner at World Precision Medicine Congress
    Professor Margaret Sleeboom-Faulkner
    Professor in Social and Medical Anthropology
    University Of Sussex
  • Dr Paul Veys at World Precision Medicine Congress
    Dr Paul Veys
    Director of Bone Marrow Transplantation and Specialty Lead
    Great Ormond Street Hospital
    Damien Bates at World Precision Medicine Congress
    Damien Bates
    Chief Medical Officer
    SanBio, Inc.
  • Dr Julia Wilson at World Precision Medicine Congress
    Dr Julia Wilson
    Associate Director
    Wellcome Trust Sanger Institute
    Professor Susan Greenfield at World Precision Medicine Congress
    Professor Susan Greenfield
    Chief Executive Officer
    Neuro Bio Ltd
  • Zami Aberman at World Precision Medicine Congress
    Zami Aberman
    President and Chief Executive Officer
    Pluristem Therapeutics Inc
    Nick Crabb at World Precision Medicine Congress
    Nick Crabb
    Programme Director – Scientific Affairs
    NICE
  • Ms Susan L. Solomon at World Precision Medicine Congress
    Ms Susan L. Solomon
    Chief Executive Officer and Co-Founder
    New York Stem Cell Foundation
    Jane Lebkowski at World Precision Medicine Congress
    Jane Lebkowski
    President of Research and Development
    Asterias Biotherapeutics

 

DOWNLOAD THE BROCHURE 

 

 

 

 

 

 

“It was a great meeting. It was such a cool idea having the meetings running at the same time, so they are interlinked but we mingle in the networking sessions, it made for an interesting and very productive event.”​ 

 

Associate Director, Wellcome Trust Sanger Institute

 

 

 

 

 

KEY AREAS OF DISCUSSION AT WORLD PRECISION MEDICINE CONGRESS 2017 INCLUDE:

Data & services: Big data, patient cohorts, data security
Diagnostics & e-health: Dx, pharma CDx development, biomarkers, e-health and connectivity
Infrastructure & investment: Cluster development, incubator/accelerator facilities, funding
Clinical programmes: Rare diseases, oncology, infectious diseases and other complex condition

 

DOWNLOAD THE BROCHURE 

 

WHY SPONSOR?

 

 

Don’t miss the chance to differentiate yourself from the competition by demonstrating your expertise to cell therapy, gene therapy, genomics and precision medicine stakeholders.

 

 

 

 

 

“It was a good meeting. I did lots of networking and met some very interesting people.”

 

Professor of Osteoarticular Pathology, Head of Manchester Medical School, Director of the MMPathIC, the Manchester MRC/ EPSRC Molecular Pathology Node, University of Manchester and Manchester Academic Health Sciences Centre

 

 

 

 

 

 

The 2017 Congress will once again be co-located with: